Neuro-inflammatory risk factors for treatment failure in 'early second stage' sleeping sickness patients treated with Pentamidine

V Lejon, D Legros, A Savignoni, M Gastellu Etchegorry, D Mbulamberi, P Büscher

    Research output: Contribution to journalA1: Web of Science-articlepeer-review

    Original languageEnglish
    JournalJournal of Neuroimmunology
    Pages (from-to)132-138
    Publication statusPublished - 2003


    • B780-tropical-medicine
    • Protozoal diseases
    • Trypanosomiasis-African
    • Trypanosoma brucei gambiense
    • Intrathecal humoral immune response
    • Intrathecal immunoglobulin synthesis
    • Immunoglobulin M
    • Pentamidine
    • Efficacy
    • Treatment failure
    • Brain involvement
    • Card agglutination test
    • Cerebrospinal fluid

    Cite this